Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis

MeSH terms

• Antirheumatic Agents / therapeutic use
• Central Nervous System Diseases / diagnosis
• Central Nervous System Diseases / etiology*
• Child
• Dermatomyositis / complications*
• Dermatomyositis / drug therapy
• Edema / diagnosis
• Edema / etiology
• Humans
• Interleukin 1 Receptor Antagonist Protein / therapeutic use
• Interleukin-1 / antagonists & inhibitors
• Macrophage Activation Syndrome / diagnosis
• Macrophage Activation Syndrome / etiology*
• Male
• Severity of Illness Index*
• Treatment Outcome